LivaNova understands its responsibility to protect the environment and minimize the Company’s environmental impact throughout the operating cycle. In its manufacturing and operations, the Company is working to optimize energy and resource usage to ultimately reduce greenhouse gas emissions and waste. Among other things, the Company’s sustainability efforts are informed by ESG Task Force member work within the organization, regulatory requirements, customer needs, and AdvaMed, MedTech Europe, and the United Kingdom (UK) National Health Service (NHS) engagement.
Planet
Environmental Sustainability
Achieving Net Zero Carbon Emissions
In line with LivaNova’s sustainability strategy, the Company is committed to achieving net zero carbon emissions by 2050 and improving resilience in a changing climate. Accordingly, LivaNova has adopted the following near-term, global targets:
- Scope 1 and Scope 2: 54.6% reduction by 2033 from a 2022 baseline year, based on the limiting warming to 1.5°C aligned pathway; and
- Scope 3: 27.5% reduction by 2033 from a 2022 baseline year, based on the limiting global warming to well-below 2°C aligned pathway.
LivaNova’s target setting method is based on the absolute contraction approach of science-based target setting and progress against these targets is incorporated within the Company’s Carbon Reduction Plan and UK Annual Report, both of which are located on the Company’s website.
Total 2023 Scope 1 and Scope 2 market-based emissions increased approximately 1% compared to 2022 to support increased sales of approximately 13%. Notably, LivaNova’s tonnes CO2e per sales revenue (US$M) decreased from 2022 by approximately 11 % due to increased operational efficiencies.
*As the Company has made strides in improving its data collection efforts in 2023, certain figures in 2022 have been restated to reflect corrections and refinements in the Company’s data collection process.
What We Are Doing
Climate Initiatives
Packaging and Product End of Life Optimizations
Climate Initiatives
In its manufacturing and operations, LivaNova is working to optimize energy and resource usage to reduce greenhouse gas emissions and waste.2023 progress towards achieving LivaNova’s Net Zero targets included:
- Updating electricity contracts to require the use of 100% clean energy sources for the Houston and Munich manufacturing facilities (2 of 6 global manufacturing sites);
- Increasing recycling at manufacturing and operational office sites with:
- Diverted waste in the Mirandola manufacturing site sold to recyclers at 34% and waste disposal with recycle code destination at 69%;
- Diverted waste in the Munich manufacturing site sold to recyclers at 62% and waste disposal with recycle code destination at 79%; and
- Continuing Zero Waste to Landfill status since December 2017 in the Gloucester, UK operational office with a recycling rate of 48%;
- Introducing use of digital business cards to reduce paper usage and waste;
- Continuing to add hybrid vehicles to the European fleet; and
- Installing EV charging stations at multiple sites.
Packaging and Product End of Life Optimizations
In furtherance of LivaNova’s decarbonization efforts, the Company is working to optimize packaging design, aiming to use the least amount of material, while ensuring adequate protection, delivery, and safe use of the product, as patient safety is paramount. LivaNova’s materials management is guided by the waste management hierarchy seeking first to reduce, reuse, and recycle (e.g., 3R). To achieve increased certified recycled content and reduced packaging waste, LivaNova has developed a global 3R Packaging Plan with initiatives embedded into the Company’s strategic plans.Currently, certain LivaNova product packaging includes certified recycled content. Specifically:
- Sterile standalone versions of InspireTM oxygenator and reservoirs are packaged using certified 100% recycled paper pulp;
- Supplier of external packaging for InspireTM perfusion tubing system (PTS) sterile standalone products is certified as Ecovadis Silver level1;
- Other product families (including Custom Packs and XTRATM Autotransfusion System) have external packaging of recycled fibers with certified recycled content ranging between 45% and >90%;
- EssenzTM Perfusion System is packaged using carton boxes with certified 58% recycled material; and
- S5TM Heart Lung Machine (HLM), XtraTM Autotransfusion System, and Xvac are packaged using carton boxes with minimum 80% recycled material.
Other Sustainability Focus Areas
